CFS Investment Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.31M Sell
24,175
-361
-1% -$77.7K 0.42% 50
2026
Q1
$5.11M Sell
24,536
-98
-0.4% -$21.7K 0.35% 67
2025
Q4
$5.63M Buy
24,634
+205
+0.8% +$46.7K 0.41% 60
2025
Q3
$5.57M Buy
24,429
+316
+1% +$64.3K 0.41% 58
2025
Q2
$4.48M Sell
24,113
-528
-2% -$98.1K 0.37% 65
2025
Q1
$5.16M Sell
24,641
-246
-1% -$47.8K 0.46% 49
2024
Q4
$4.42M Buy
24,887
+246
+1% +$45.2K 0.4% 54
2024
Q3
$4.87M Buy
24,641
+72
+0.3% +$13.4K 0.41% 50
2024
Q2
$4.21M Sell
24,569
-1,055
-4% -$175K 0.34% 58
2024
Q1
$4.67M Sell
25,624
-93
-0.4% -$16K 0.78% 25
2023
Q4
$3.98M Sell
25,717
-1,107
-4% -$161K 0.72% 26
2023
Q3
$4M Buy
26,824
+5,033
+23% +$739K 0.64% 31
2023
Q2
$2.94M Sell
21,791
-1,509
-6% -$221K 0.38% 47
2023
Q1
$3.71M Buy
23,300
+2,135
+10% +$326K 0.68% 28
2022
Q4
$3.42M Sell
21,165
-2,468,186
-99% -$378M 0.78% 19
2022
Q3
$2.49M Buy
2,489,351
+2,470,696
+13,244% +$355M 0.57% 27
2022
Q2
$2.86M Sell
18,655
-3,027,554
-99% -$463M 0.44% 43
2022
Q1
$19K Buy
3,046,209
+3,027,814
+16,460% +$440M 0.08% 116
2021
Q4
$2.52M Sell
18,395
-1,017
-5% -$120K 0.34% 59
2021
Q3
$2.09M Buy
+19,412
New +$2.22M 0.29% 78
2020
Q4
$2.16M Buy
+20,135
New +$1.93M 0.34% 61

Other funds holding ABBV

CFS Investment Advisory Services's ABBV Position: Q2 2026 in Review

CFS Investment Advisory Services reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $77.7K and leaving 24,175 shares worth $6.31M. The position accounts for 0.42% of the portfolio, ranked #50.

CFS Investment Advisory Services first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. 1,742 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CFS Investment Advisory Services held 24,175 shares of AbbVie worth $6.31M as of Q2 2026.
  • CFS Investment Advisory Services sold 361 AbbVie shares in Q2 2026, an estimated $77.7K.
  • AbbVie made up 0.42% of CFS Investment Advisory Services's portfolio in Q2 2026, its #50 holding.
  • CFS Investment Advisory Services first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • 1,742 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CFS Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.